Our History

Leading microbiologist, Dr. Liubov Sichel, founded Stellar Biotics LLC (formerly Pure Research Products, LLC) in 2002, for the research and development of immune-oriented nutraceutical supplements for humans and pets.

Using unique probiotic cultures, Cell Fragment Technology™, and phytonutrients as prebiotics, Dr. Sichel created supplements that work via immune cell receptors to help regulate the immune response. These supplements, called metabiotics, are based on the latest postbiotics research and are the next generation of probiotics. 

We are most-widely known as the maker of del-IMMUNE V® - the leading non-prescription cell fragment supplement backed by clinical research on the U.S. market. del-IMMUNE V is a bioactive metabolite and cell structural substance (muramyl polypeptides and DNA motifs), derived from the cell of a selected probiotic strain,“ Lactobacillus rhamnosus DV.” Scientific studies have shown that del-IMMUNE V components can interact with certain immune cells, including cells producing secretory immunoglobulin A (sIgA), interferons (IFNs) and other immune mediators, known to play a critical role in healthy immune system function. del-IMMUNE V replicates the process that occurs naturally in the human body, between healthy microbiota and immune receptors. These interactions are realized in immune signal production and help the innate immune system protect the body against all kinds of pathogens and threats, including stress.

 

We develop other products which combine del-IMMUNE V, including our probiotic, delPRO, and our four pet products, which combine del-IMMUNE V with probiotics and other ingredients, to address distinct pet health needs. We also produce Daily Throat Remedy which contains peptides from bovine colostrum to regulate the immune system.

We sell solely online to consumers through our company website and Amazon or through healthcare practitioners and providers. The full line of our immune products are made and manufactured in the United States and available to customers world-wide.

Dr. Sichel continues to collaborate on scientific and clinical research with companies and universities in the United States, Canada, Ukraine, Bulgaria, and Poland to support the development of new formulations that combine del-IMMUNE V with other recognized and innovative therapeutics.